SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Laboratory Corp. of America Holdings – ‘10-K’ for 12/31/23 – ‘EX-31.1’

On:  Monday, 2/26/24, at 3:35pm ET   ·   For:  12/31/23   ·   Accession #:  920148-24-14   ·   File #:  1-11353

Previous ‘10-K’:  ‘10-K’ on 2/28/23 for 12/31/22   ·   Latest ‘10-K’:  This Filing   ·   25 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

 2/26/24  Lab Corp. of America Holdings     10-K       12/31/23  122:18M

Annual Report   —   Form 10-K   —   SEA’34

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Annual Report                                       HTML   3.13M 
 2: EX-10.15    Material Contract                                   HTML     34K 
 3: EX-21       Subsidiaries List                                   HTML     43K 
 4: EX-23.1     Consent of Expert or Counsel                        HTML     29K 
 5: EX-24.1     Power of Attorney                                   HTML     31K 
14: EX-24.10    Power of Attorney                                   HTML     31K 
15: EX-24.11    Power of Attorney                                   HTML     31K 
 6: EX-24.2     Power of Attorney                                   HTML     31K 
 7: EX-24.3     Power of Attorney                                   HTML     31K 
 8: EX-24.4     Power of Attorney                                   HTML     31K 
 9: EX-24.5     Power of Attorney                                   HTML     31K 
10: EX-24.6     Power of Attorney                                   HTML     31K 
11: EX-24.7     Power of Attorney                                   HTML     31K 
12: EX-24.8     Power of Attorney                                   HTML     31K 
13: EX-24.9     Power of Attorney                                   HTML     31K 
19: EX-97       Clawback Policy re: Recovery of Erroneously         HTML     59K 
                Awarded Compensation                                             
16: EX-31.1     Certification -- §302 - SOA'02                      HTML     34K 
17: EX-31.2     Certification -- §302 - SOA'02                      HTML     34K 
18: EX-32       Certification -- §906 - SOA'02                      HTML     32K 
25: R1          Document and Entity Information Document            HTML     95K 
26: R2          Cover                                               HTML     37K 
27: R3          Other Liabilities                                   HTML     39K 
28: R4          Other Liabilities                                   HTML     39K 
29: R5          Other Liabilities                                   HTML     42K 
30: R6          Consolidated Balance Sheets                         HTML    220K 
31: R7          Consolidated Statements of Operations               HTML    152K 
32: R8          Consolidated Statements of Comprehensive Earnings   HTML     80K 
33: R9          Consolidated Statements of Changes in               HTML     97K 
                Shareholders' Equity                                             
34: R10         Consolidated Statements of Cash Flows               HTML    164K 
35: R11         Summary of Significant Accounting - Earnings Per    HTML     69K 
                Share                                                            
36: R12         Summary of Significant Accounting - Property,       HTML     51K 
                Plant and Equipment                                              
37: R13         Summary of Significant Accounting - Intangible      HTML     51K 
                Assets                                                           
38: R14         Summary of Significant Accounting Policies          HTML    106K 
39: R15         Discontinued Operations                             HTML     63K 
40: R16         Revenue (Notes)                                     HTML    150K 
41: R17         Business Acquisitions                               HTML    148K 
42: R18         Restructuring and Related Activities                HTML     57K 
43: R19         Leases (Notes)                                      HTML     87K 
44: R20         Property, Plant and Equipment, Net                  HTML     45K 
45: R21         Goodwill and Intangible Assets                      HTML     90K 
46: R22         Accrued Expenses and Other                          HTML     38K 
47: R23         Debt                                                HTML     70K 
48: R24         Preferred Stock and Common Shareholders' Equity     HTML     75K 
49: R25         Income Taxes                                        HTML    129K 
50: R26         Stock Compensation Plans                            HTML    105K 
51: R27         Commitments and Contingent Liabilities              HTML     72K 
52: R28         Pension and Postretirement Plans                    HTML    252K 
53: R29         Fair Value Measurements                             HTML     88K 
54: R30         Derivative Instruments and Hedging Activities       HTML     55K 
55: R31         Supplemental Cash Flow Information                  HTML     42K 
56: R32         Business Segment Information                        HTML     90K 
57: R33         Subsequent Events                                   HTML     32K 
58: R34         Pay vs Performance Disclosure                       HTML     42K 
59: R35         Insider Trading Arrangements                        HTML     64K 
60: R36         Summary of Significant Accounting Policies          HTML    159K 
                (Policies)                                                       
61: R37         Summary of Significant Accounting Policies          HTML     72K 
                (Tables)                                                         
62: R38         Revenue (Tables)                                    HTML    114K 
63: R39         BUSINESS ACQUISITIONS & DISPOSITIONS Business       HTML     35K 
                Acquisitions (Tables)                                            
64: R40         Restructuring and Related Activities (Tables)       HTML     55K 
65: R41         Leases (Tables)                                     HTML    114K 
66: R42         Property, Plant and Equipment, Net (Tables)         HTML     44K 
67: R43         Goodwill and Intangible Assets (Tables)             HTML     95K 
68: R44         Accrued Expenses and Other (Tables)                 HTML     39K 
69: R45         Debt (Tables)                                       HTML     86K 
70: R46         Preferred Stock and Common Shareholders' Equity     HTML     73K 
                (Tables)                                                         
71: R47         Income Taxes (Tables)                               HTML    134K 
72: R48         Stock Compensation Plans (Tables)                   HTML     90K 
73: R49         PENSION AND POSTRETIREMENT PLANS Pension and        HTML    246K 
                Postretirement Plans (Tables)                                    
74: R50         Fair Value Measurements (Tables)                    HTML     69K 
75: R51         Derivative Instruments and Hedging Activities       HTML     55K 
                (Tables)                                                         
76: R52         Supplemental Cash Flow Information (Tables)         HTML     42K 
77: R53         Business Segment Information (Tables)               HTML     85K 
78: R54         Summary of Significant Accounting Policies          HTML    116K 
                (Details)                                                        
79: R55         Discontinued Operations and Disposal Groups         HTML     86K 
                (Details)                                                        
80: R56         Revenue (Details)                                   HTML    133K 
81: R57         Receivables, Loans, Notes Receivable, and Others    HTML     70K 
                (Details)                                                        
82: R58         Business Acquisitions (Details)                     HTML    241K 
83: R59         Business Acquisitions & Dispositions Dispositions   HTML     83K 
                (Details)                                                        
84: R60         BUSINESS ACQUISITIONS & DISPOSITIONS Envigo         HTML     88K 
                (Details)                                                        
85: R61         Restructuring and Related Activities (Details)      HTML     79K 
86: R62         Leases (Details)                                    HTML     42K 
87: R63         Leases - Lease Cost (Details)                       HTML     39K 
88: R64         LEASES - Supplemental Cash Flow (Details)           HTML     41K 
89: R65         LEASES - Supplemental Balance Sheet (Details)       HTML     60K 
90: R66         LEASES - Maturity of Leases (Details)               HTML     74K 
91: R67         Property, Plant and Equipment, Net (Details)        HTML     65K 
92: R68         Goodwill and Intangible Assets (Details)            HTML     68K 
93: R69         Goodwill and Intangible Assets - Schedule of        HTML     57K 
                Goodwill (Details)                                               
94: R70         Goodwill and Intangible Assets - Components of      HTML     76K 
                Identifiable Intangible Assets (Details)                         
95: R71         Goodwill and Intangible Assets - Summary of         HTML     50K 
                Acquired Amortizable Intangible Assets (Details)                 
96: R72         Accrued Expenses and Other (Details)                HTML     38K 
97: R73         Debt - Schedule of Short-Term Debt (Details)        HTML     55K 
98: R74         Debt - Schedule of Long-Term Debt (Details)         HTML     76K 
99: R75         Debt - Credit Facilities (Details)                  HTML     54K 
100: R76         Debt - Covertible Subordinated Notes (Details)      HTML     48K  
101: R77         Debt - Senior Notes (Details)                       HTML     65K  
102: R78         Preferred Stock and Common Shareholders' Equity     HTML    182K  
                (Details)                                                        
103: R79         Income Taxes (Details)                              HTML    212K  
104: R80         Stock Compensation Plans (Details)                  HTML    139K  
105: R81         (Details)                                           HTML     40K  
106: R82         Commitments and Contingent Liabilities (Details)    HTML     32K  
107: R83         Pension and Postretirement Plans (Details)          HTML    255K  
108: R84         Pension and Postretirement Plans - Fair Value of    HTML    172K  
                Plan Assets (Details)                                            
109: R85         Pension and Postretirement Plans, Other             HTML    108K  
                Disclosures (Details)                                            
110: R86         PENSION AND POSTRETIREMENT PLANS - Funded Status    HTML     46K  
                (Details)                                                        
111: R87         Fair Value Measurements (Details)                   HTML     77K  
112: R88         Derivative Instruments and Hedging Activities       HTML     58K  
                (Schedule of Derivative Instruments in Statement                 
                of Financial Position at Fair Value) (Details)                   
113: R89         Derivative Instruments and Hedging Activities       HTML     54K  
                (Effects of Interest Rate Swap on Other                          
                Comprehensive Income) (Details)                                  
114: R90         Supplemental Cash Flow Information (Details)        HTML     39K  
115: R91         Business Segment Information (Details)              HTML    117K  
116: R92         Subsequent Events (Details)                         HTML     42K  
117: R9999       Uncategorized Items - lh-20231231.htm               HTML     31K  
119: XML         IDEA XML File -- Filing Summary                      XML    201K  
122: XML         XBRL Instance -- lh-20231231_htm                     XML   4.16M  
118: EXCEL       IDEA Workbook of Financial Report Info              XLSX    276K  
21: EX-101.CAL  XBRL Calculations -- lh-20231231_cal                 XML    276K 
22: EX-101.DEF  XBRL Definitions -- lh-20231231_def                  XML   1.59M 
23: EX-101.LAB  XBRL Labels -- lh-20231231_lab                       XML   3.35M 
24: EX-101.PRE  XBRL Presentations -- lh-20231231_pre                XML   2.29M 
20: EX-101.SCH  XBRL Schema -- lh-20231231                           XSD    268K 
120: JSON        XBRL Instance as JSON Data -- MetaLinks              856±  1.29M  
121: ZIP         XBRL Zipped Folder -- 0000920148-24-000014-xbrl      Zip   1.09M  


‘EX-31.1’   —   Certification — §302 – SOA’02


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



 C:   C: 
  Document  

Exhibit 31.1

Certification

I, Adam H. Schechter, certify that:

1. I have reviewed this Annual Report on Form 10-K of Laboratory Corporation of America Holdings;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rule 13a-15(f) and 15d-15(f)) for the registrant and have:

a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation;  and

d) disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date:February 26, 2024  
 By:/s/ ADAM H. SCHECHTER
  Adam H. Schechter
  Chief Executive Officer
  (Principal Executive Officer)


Dates Referenced Herein

This ‘10-K’ Filing    Date    Other Filings
Filed on:2/26/24None on these Dates
For Period end:12/31/23
 List all Filings 


25 Previous Filings that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

10/30/23  Lab Corp. of America Holdings     10-Q        9/30/23   62:8.3M
 8/04/23  Lab Corp. of America Holdings     10-Q        6/30/23   62:7.7M
 7/03/23  Lab Corp. of America Holdings     8-K:1,2,8,9 6/30/23   15:1.8M
 2/28/23  Lab Corp. of America Holdings     10-K       12/31/22  116:20M
 5/26/21  Lab Corp. of America Holdings     8-K:1,9     5/26/21   12:520K                                   Donnelley … Solutions/FA
 5/04/21  Lab Corp. of America Holdings     10-Q        3/31/21   72:8.9M
 3/03/21  Lab Corp. of America Holdings     8-K/A:4,9  11/02/20   13:182K
 2/25/21  Lab Corp. of America Holdings     10-K       12/31/20  116:19M
11/05/20  Lab Corp. of America Holdings     8-K:4,9    11/02/20   11:147K                                   Donnelley … Solutions/FA
 7/31/20  Lab Corp. of America Holdings     10-Q        6/30/20   80:12M
 5/08/20  Lab Corp. of America Holdings     10-Q        3/31/20   78:73M
11/25/19  Lab Corp. of America Holdings     8-K:1,9    11/25/19   12:504K                                   Donnelley … Solutions/FA
 6/05/19  Lab Corp. of America Holdings     8-K:5,7,9   6/04/19    3:314K                                   Donnelley … Solutions/FA
 6/03/19  Lab Corp. of America Holdings     8-K:1,2,7,9 6/03/19    4:647K                                   Donnelley … Solutions/FA
 8/22/17  Lab Corp. of America Holdings     8-K:1,8,9   8/22/17    5:516K                                   Donnelley … Solutions/FA
 5/16/16  Lab Corp. of America Holdings     8-K:5,9     5/11/16    3:313K                                   Donnelley … Solutions/FA
 1/30/15  Lab Corp. of America Holdings     8-K:1,8,9   1/30/15    7:815K                                   Donnelley … Solutions/FA
11/01/13  Lab Corp. of America Holdings     8-K:1,8,9  10/29/13    5:480K                                   Donnelley … Solutions/FA
11/19/10  Lab Corp. of America Holdings     8-K:1,8,9  11/16/10    6:1.2M
 2/26/08  Lab Corp. of America Holdings     10-K        2/26/08   17:1.3M
 2/27/07  Lab Corp. of America Holdings     10-K       12/31/06   17:1.2M                                   Edgar Ease Svc Bureau/FA
 8/08/05  Lab Corp. of America Holdings     10-Q        8/08/05    8:511K
 3/03/05  Lab Corp. of America Holdings     10-K        3/03/05   17:1.4M
11/01/04  Lab Corp. of America Holdings     10-Q       11/01/04    6:486K
 3/18/02  Lab Corp. of America Holdings     10-K       12/31/01    7:582K
Top
Filing Submission 0000920148-24-000014   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Thu., May 16, 1:08:28.4pm ET